skip to main content
Show Results with:

Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation

Rotow, Julia K. et al.

Clinical lung cancer. Volume 20:Number 2 (2019, March); pp e137-e141 -- Elsevier

Online access

Searching Remote Databases, Please Wait